A CDC panel decided to end the universal birth dose of a hepatitis B vaccine for newborns, with some officials pointing to ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...
A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...
Some countries recommend fewer childhood vaccines, but that plan is riskier in America, which lacks universal health care.
Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
On the campaign trail last October, President Trump promised to let his health secretary, Robert F. Kennedy Jr., “go wild on ...
Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...